2010
DOI: 10.2174/157016110792006978
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?

Abstract: Vitamin D deficiency is a well-established risk factor for bone disease. Emerging data suggest a pleiotropic role of this agent in a variety of functions in humans. Epidemiological studies indicate an inverse association between vitamin D deficiency and the prevalence of cardiovascular disease (CVD), as well as individual cardiometabolic risk factors, such as hypertension, diabetes, dyslipidemia and the metabolic syndrome. Moreover, vitamin D deficiency has been implicated in the atherosclerotic process. This … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
47
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(49 citation statements)
references
References 0 publications
2
47
0
Order By: Relevance
“…Our results are consistent with previous reports showing an influence of vitamin D level deficiency on chronic inflammatory, vascular and brain diseases [17]. Vitamin D is known to play a pivotal role in immunomodulation by regulating proinflammatory cells and the production of inflammatory cytokines, both of which are crucial steps in the pathogenesis of cardiovascular and inflammatory diseases [15].…”
Section: Rock Activity In Leukocytes and Plasma Crp Activity Are Not Cosupporting
confidence: 93%
See 1 more Smart Citation
“…Our results are consistent with previous reports showing an influence of vitamin D level deficiency on chronic inflammatory, vascular and brain diseases [17]. Vitamin D is known to play a pivotal role in immunomodulation by regulating proinflammatory cells and the production of inflammatory cytokines, both of which are crucial steps in the pathogenesis of cardiovascular and inflammatory diseases [15].…”
Section: Rock Activity In Leukocytes and Plasma Crp Activity Are Not Cosupporting
confidence: 93%
“…Indeed, cholecalciferol (vitamin D3), identified as potentially disease-modifying by using unbiased target-agnostic screening, was subsequently shown to decrease CCM lesion burden in a murine model of CCM, and to inhibit ROCK activity, known to affect CCM development [16]. Plasma vitamin D level has been associated with a favorable lipid profile related to inflammation and cardiovascular diseases [17], while an inverse association of vitamin D level with CRP has also been reported [15]. Thus, we hypothesize that these biomarkers would reflect the severity of CCM disease over time or with recent clinical behavior.…”
mentioning
confidence: 99%
“…Considering the high prevalence of vitamin deficiency and the growing body of evidences that links it to diseases, it may be sufficient to form a basis for population wide intervention. Since vitamin D is mainly and easily acquired through the skin under exposure to UVb sunlight, such recommendation may yet be another reason for an active and health lifestyle [20][21][22][23][24][25][26][27][28][29].…”
Section: Critical Summationmentioning
confidence: 99%
“…Better detection and awareness of this deficiency may also be relevant in clinical practice but would not explain all the epidemiological findings 1,[6][7][8] . Vitamin D supplementation seems to be clinically relevant because of links with vascular risk factors 9 . For example, vitamin D deficiency is associated with an increased risk of insulin resistance, metabolic syndrome and diabetes [10][11][12][13][14] , at least in some studies 15 .…”
Section: I a L D I S T R I B U T I O N U N A U T H O R I Z E D U S mentioning
confidence: 99%